Literature DB >> 21675906

Renal improvement in myeloma with bortezomib plus plasma exchange.

Brian L Burnette, Nelson Leung, S Vincent Rajkumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21675906     DOI： 10.1056/NEJMc1101834

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma.

Authors:  S K Kumar; E Ma; A E Engebretson; F K Buadi; M Q Lacy; A Dispenzieri; M S Duh; M-H Lafeuille; P Lefebvre; W Y Cheng; K Dea; D Rembert; D Patt; L Niculescu; M Quick; S V Rajkumar
Journal:  Leukemia       Date:  2015-08-14       Impact factor: 11.528

Review 2.  Onco-nephrology: AKI in the cancer patient.

Authors:  Albert Q Lam; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

3.  Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.

Authors:  Mayuko Kawabe; Izumi Yamamoto; Ai Katsuma; Naomi Hayashi; Yo Komatsuzaki; Yasuyuki Nakada; Akihiro Shimizu; Yudo Tanno; Ichiro Ohkido; Nobuo Tsuboi; Kazuhito Suzuki; Takaki Shimada; Yoji Ogasawara; Katsuki Sugiyama; Keisuke Aiba; Takashi Yokoo
Journal:  CEN Case Rep       Date:  2016-08-11

4.  Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.

Authors:  Frank Bridoux; Pierre-Louis Carron; Brigitte Pegourie; Eric Alamartine; Karine Augeul-Meunier; Alexandre Karras; Bertrand Joly; Marie-Noëlle Peraldi; Bertrand Arnulf; Cécile Vigneau; Thierry Lamy; Alain Wynckel; Brigitte Kolb; Bruno Royer; Nolwenn Rabot; Lotfi Benboubker; Christian Combe; Arnaud Jaccard; Bruno Moulin; Bertrand Knebelmann; Sylvie Chevret; Jean-Paul Fermand
Journal:  JAMA       Date:  2017-12-05       Impact factor: 56.272

5.  European Myeloma Network guidelines for the management of multiple myeloma-related complications.

Authors:  Evangelos Terpos; Martina Kleber; Monika Engelhardt; Sonja Zweegman; Francesca Gay; Efstathios Kastritis; Niels W C J van de Donk; Benedetto Bruno; Orhan Sezer; Annemiek Broijl; Sara Bringhen; Meral Beksac; Alessandra Larocca; Roman Hajek; Pellegrino Musto; Hans Erik Johnsen; Fortunato Morabito; Heinz Ludwig; Michele Cavo; Hermann Einsele; Pieter Sonneveld; Meletios A Dimopoulos; Antonio Palumbo
Journal:  Haematologica       Date:  2015-10       Impact factor: 9.941

Review 6.  Novel approaches for reducing free light chains in patients with myeloma kidney.

Authors:  Colin A Hutchison; Joan Bladé; Paul Cockwell; Mark Cook; Mark Drayson; Jean-Paul Fermand; Efstathios Kastritis; Robert Kyle; Nelson Leung; Sonia Pasquali; Christopher Winearls
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

7.  Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.

Authors:  Nelson Leung; Morie Gertz; Robert A Kyle; Fernando C Fervenza; Maria V Irazabal; Alfonso Eirin; Shaji Kumar; Stephen S Cha; S Vincent Rajkumar; Martha Q Lacy; Steve R Zeldenrust; Francis K Buadi; Suzanne R Hayman; Samih H Nasr; Sanjeev Sethi; Marina Ramirez-Alvarado; Thomas E Witzig; Sandra M Herrmann; Angela Dispenzieri
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 8.  [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].

Authors:  V Gödecke; J J Schmidt; J H Bräsen; C Koenecke; H Haller
Journal:  Internist (Berl)       Date:  2019-01       Impact factor: 0.743

Review 9.  Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.

Authors:  P Fabbrini; K Finkel; M Gallieni; G Capasso; M Cavo; A Santoro; S Pasquali
Journal:  J Nephrol       Date:  2016-10-18       Impact factor: 3.902

10.  Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.

Authors:  Kevin W Finkel; Eric P Cohen; Anushree Shirali; Ala Abudayyeh
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.